Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol-Reference-Cited by-同舟云学术

Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol

Published:2023-03-16 Issue:3 Volume:31 Page:1559-1560
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Kelleni Mina T.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-023-01180-6.pdf

Reference10 articles.

1. Hou Y, Ge S, Li X, Wang C, He H, He L (2021) Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis. Chem Biol Interact 338:109420

2. Kelleni MT (2022) NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Inflammopharmacology 30:343–348

3. Kelleni MT (2023a) Evolution of SARS CoV-2 omicron subvariants BF.7 and XBB.1.5: time to follow Africa and abort all COVID restrictions. J Infect (In Press)

4. Kelleni MT (2023b) Real-life practice of the Egyptian Kelleni’s protocol in the current tripledemic: COVID-19, RSV and influenza. J Infect 86:154–225

5. Lui K, Wilson MP, Low G (2021) Abdominal imaging findings in patients with SARS-CoV-2 infection: a scoping review. Abdominal Radiol 46:1249–1255

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment;World Journal of Experimental Medicine;2024-03-20

2. Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach;Inflammopharmacology;2024-01-31

3. The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one;Inflammopharmacology;2023-06-16